Infectious Disease Molecular biology – Eurofins Biomnis

 

A large part of our activity involves the detection, quantification and, classification of viruses with DNA or RNA that are difficult, or currently impossible, to cultivate (HIV, hepatitis B and C viruses, papillomavirus, CMV, EBV, parvovirus, etc.). Real-time PCR methods are used because they are highly effective but also because they reduce turn-around time. The use of automation and electronic-processing, from the extraction of samples through to the final results, improves the reproducibility and accuracy of those results.

We also perform extremely specialised PCRs which greatly helps in the detection of micro-organisms that are hard, or currently impossible, to cultivate: Treponema pallidum, Mycoplasma genitalium, Haemophilus ducreyi, Kingella kingae, Tropheryma whiplei, Bartonella spp and slow-growth cultures such as Legionella pneumophila.

In order to make up for the lack of sensitivity of the more traditional diagnosis techniques, we developed Pnemocystis jirovecii and Clostridium difficile PCRs.

For epidemics, we developed an A H1N1 influenza PCR, and, more recently, PCRs for chikungunya and dengue.

In addition, we have developed PCRs used to diagnose less-common viral infections seen in immuno-compromised patients, including JC, BK, Human Herpes virus 6, HHV 7, and HHV8 PCRs.

We also have 2 certified pathologists who contribute their expertise to the diagnosis of prenatal infections.

 

Mettez à jour votre navigateur pour consulter ce site

Mettez à jour votre navigateur pour consulter ce site